Home・Lista de Ações・Hims & Hers Health Inc

Hims & Hers Health Inc

Abrir

SetorConsumo Básico

32.07 4.09

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

30.24

Máximo

31.73

Indicadores-chave
By Trading Economics
Rendimento	-113M -92M
Vendas	-9.7M 608M
P/E Médio do Setor	57.137 33.699
EPS	-0.19
Margem de lucro	-15.148
Funcionários	2,442
EBITDA	-107M -80M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	-3.05% downside

Dividendos
By Acuity
Próximos Ganhos	10 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	266M 7B
Abertura anterior	27.98
Fecho anterior	32.07

Sentimento de Notícias

By Acuity

50%

52 / 130 Ranking em Consumer defensive

Hims & Hers Health Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 23:41 UTC

News

Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.

31 de jul. de 2026, 19:36 UTC

Social Media

News

Hims & Hers Health Inc is trading higher amid social media discussions about potential undervaluation, despite facing a lawsuit over user health data practices.

30 de jul. de 2026, 20:11 UTC

Hims & Hers Health Inc shares are higher today amid high trading volume. Broader economic data showed mixed signals, contributing to market volatility.

29 de jul. de 2026, 23:16 UTC

Social Media

News

Hims & Hers Health shares declined in after-market trading amid legal challenges from the FTC over alleged privacy violations and a securities fraud investigation.

28 de jul. de 2026, 23:41 UTC

Hims & Hers Health shares declined in after-market trading, remaining near the lower end of their one-month range amid broader market pressures from Asian tech losses.

27 de jul. de 2026, 20:03 UTC

News

Social Media

Hims & Hers Health shares rise amid FDA committee's endorsement of peptides, seen as a significant step toward market access for treatments.

24 de jul. de 2026, 23:16 UTC

Social Media

Hims & Hers Health Inc. shares rose after-hours following positive votes from an FDA/HHS panel on six peptides, with a final decision expected in up to 12 months.

23 de jul. de 2026, 23:26 UTC

News

Hims & Hers Health Inc shares are higher after an FDA advisory panel recommended easing restrictions on a popular peptide and Canaccord reiterated a Buy rating.

22 de jul. de 2026, 23:16 UTC

News

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

21 de jul. de 2026, 17:31 UTC

News

Hims & Hers Health Inc shares are declining amid an investigation into potential wrongdoing and concerns over FDA approval of key peptides.

20 de jul. de 2026, 18:37 UTC

News

Hims & Hers Health Inc. is trading higher amid broader market dynamics, despite earlier pulling back from a session high.

Comparação entre Pares

Variação de preço

Hims & Hers Health Inc Previsão

Preço-alvo

By TipRanks

-3.05% parte inferior

Previsão para 12 meses

Média 29.88 USD -3.05%

Máximo 40 USD

Mínimo 21 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para Hims & Hers Health Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

Comprar

Manter

Vender

Com base em 13 analistas que deram avaliações de ações para Hims & Hers Health Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

52 / 130 Ranking em Consumo Básico

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.